ASXC — Asensus Surgical Share News
0.000.00%
Last trade - 00:00- $81.58m
- $89.11m
- $8.58m
Brief: Asensus Surgical Inc Announces Non-Binding Acquisition Proposal And Exclusivity Arrangement With KARL STORZ SE & Co. KG
Brief: Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update
Brief: Asensus Announces Sale Of Senhance Robotic System In Romania
Asensus jumps on sale of robotic surgical system
Asensus Surgical soars after AI collaboration with NVIDIA
Brief: Asensus Surgical Announces Collaboration With Nvidia
Brief: Asensus Surgical Inc Says As Of June 30, Co And Karl Storz Have Not Reached Agreement On Final Terms Of A Definitive Agreement
Brief: Asensus Surgical, Inc. Reports Operating And Financial Results For The First Quarter 2023
Brief: Asensus Surgical Receives FDA 510(K) Clearance For Pediatric Indication For Senhance Surgical System
Brief: Asensus Surgical, Inc. Reports Operating And Financial Results For Q4 And Full Year 2022
Brief: Asensus Surgical Announces Machine Learning And Cloud Infrastructure Collaboration With Google Cloud To Advance Performance-Guided Surgery
Asensus rises on expanded EU nod for surgical assistance tool
Brief: Asensus Surgical Receives CE Mark For Expanded Machine Vision Capabilities
Brief: Asensus Surgical Provides Preliminary 2022 Year-End Corporate Update
Brief: Asensus Announces Senhance Program Initiation At Kashiwa Kosei General Hospital Of Japan
Brief: Asensus Announces Additional Senhance Surgical System Sale
Brief: Asensus Surgical Inc Reports Operating And Financial Results For The Third Quarter 2022
Brief: Asensus Surgical Announces Ludwig Maximilians University In Germany To Initiate Senhance Pediatric Surgery Program
Brief: Asensus Surgical Announces Saiseikai Shiga Hospital In Japan To Initiate Senhance Surgery Program